AGAINST RHEUMATOID ARTHRITIS.
We are committed to attacking inflammatory diseases like rheumatoid arthritis (RA). But we’re not alone. We problem-solve across our global offices in 35 countries. We collaborate with external partners to develop innovative therapeutic approaches, and we aim to further advance the care of patients.